Member Info for megatro

Thanks regulator -That was my thought also.

Thinking about the contract length. Could it be a year. The £374m would appear on the low side for 204m antigen tests over 2 years. I appreciate 2m p/w capcity may not be reserved for govt or for this test in its entirety.

I presume the contract (albeit redacted) will be published in coming days?

Is the 347m for a quarter I'm struggling to find details of length of contract etc

https://bidstats.uk/tenders/2021/W10/746782729

Is there any confirmation of length of contract? Hopefully on bid stats today if not yet published.

https://bidstats.uk/tenders/2021/W10/746586477

This tender went under my radar - published thursday. Has anyone else commented on it.

Also I know we've discussed the 30 day publishing date for antigen once or twice :) there was the anyltibody tender that finished on 31/01/2021 any news on that.
https://bidstats.uk/tenders/2020/W52/741539862

That's crossed my mind a few times, why not make surescreen. Doesn't their contract with govt expressly allow that? Anyone have any ideas?

Hi Steve can't see that was this the one yesterday or another one today. Thanks

https://bidstats.uk/tenders/2021/W07/745144624

Surescreen contract
15/01 signed. Published 17/02

not sure when omega signed contract I highly doubt it was pre 7am on the 11/02 so at the least it would have been signed on 10/02?

Yeah regardless of RNS update. You'd think it would warrant a tweet to acknowledge!

Does that constitute an RNS release? Can't see it on Abingdon page here Or on the LSE RNS website.

Some people have tried to convince this board that ODX are taking a gamble by recruiting the staff without published orders. Lo and behold Abingdon have done it as well. In what world would an established company (let alone 2) do this without insight for future demand. It would be career suicide for CEOs if they were "gambling". so I have taken great confidence in Abingdons increase in staff. As I have with Omegas.

I liked this part -
"The Company is making good progress in the approval of AbC-19™ for testing in the US as well as with over 30 other countries worldwide. The Company has identified customers in seven countries that are being prioritised internally as Tier 1 commercial targets where, following registration of AbC-19™, the Company anticipates significant sizeable orders, ahead of the end of Abingdon Health's financial year. "

Any hope that Abingdons interim results tomorrow will provide an update on current state of play on ABC?

Look at their last tweet on job numbers on 15 Feb. on target and now increasing even further to 250+ what's going on!!! All hail the king.

Full commerical rollout mid march? Wheres that info come from? For the avoidance of doubt.

I hold
I'm not a bed wetter
I like to corroborate statements of the nature you have made.

Have I missed something? The TT has been completed? Where did that info come from?

Is there anything preventing ODX publishing it?

What test could be sold to U.S?

It's at the bottom of the narrative on the RNS

I'm also curious of the potential longevity/demand of this service If MHRA approval is given for home use of ABC. Of course that would also mean massive potential demand for ABC so good position to be in.